C71T
CANCELLED SECTION 71
02/06/2026
Back to search
Official data from USPTO
OOCUITY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OOCUITY
ST13
US500000079246377Class
5, 10, 42, 44
Filing
79246377
Registration
5809477
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
03/03/2026
Trademark type
Word
Nice classes
5, 10, 42, 44
Filing date
09/10/2018
Registration date
07/23/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/06/2026
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
FR
Examiner
O'BRIEN, JENNIFER LYNN
Law office
N20
Current location
POST REGISTRATION
Holders and representatives
Holders
NANOBIOTIX
Representatives
Max Vern Amster, Rothstein & Ebenstein LLP
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for medical usefor the treatment of brain diseases and disorders; Pharmaceutical preparation for the diagnosis and treatment of brain diseases and disorders; Pharmaceutical preparation for medical use namelyfor modifying the bioavailability of therapeutic agents; Pharmaceutical preparation for medical use namelyfor the diagnosis and treatment of tumors; Pharmaceutical preparation for medical use particularly for the treatment of Parkinson's diseaseAlzheimer's diseaseepilepsy and all types of neurological and neuropsychiatric diseases and disorders; Pharmaceutical preparation for medical use namelyfor the treatment of * treating the * symptoms of Parkinson's diseasesymptoms of Alzheimer's diseasesymptoms of epilepsy and symptoms relating to all kinds * related to any type * of neurological and neuropsychiatric diseases and disorders * disorders and diseases * ; Pharmaceutical preparation for the diagnosis and treatment of neurological disorders and diseases for use with deep brain stimulationelectrical transcranial stimulationtranscranial direct-current stimulationtranscranial magnetic stimulationany form of electromagnetic stimulation in the nature of lightmagnetic fieldelectric fieldradio frequency or ultrasound stimulation; health * care * productspharmaceutical preparations for central nervous systems disorder treatment; radiological contrast substances for medical use; nanoparticles for medical usenanomaterial-based chemical preparations for medical and pharmaceutical purpose for the treatment of cancercentral nervous system disordercardiovascularimmunologicalgastrointestinalmetabolic and infectious diseases ; Drug delivery agents in the form of nanomaterial-based preparation for the delivery of therapeutic agents; chemical reagents for medical use; bacteriological preparations for medical use; biological preparations for medical usefor the treatment of cancercentral nervous system disordercardiovascularimmunologicalgastrointestinalmetabolic and infectious diseases; enzymes for medical use; enzyme preparations for medical use; chemical preparations for medical or pharmaceutical usefor the treatment of cancercentral nervous system disorderscardiovascularimmunologicalgastrointestinalmetabolic and infectious diseases; diagnostic products for medical usediagnostic preparations for medical purposes; drugs for medical usenanomaterial-based pharmaceutical preparation of active ingredients for the treatment of cancercentral nervous system disorderscardiovascularimmunologicalgastrointestinalmetabolic and infectious diseases; medicines for human medicinemedical preparations for the treatment of cancercentral nervous system disorderscardiovascularimmunologicalgastrointestinalmetabolic and infectious diseases; tonics being medicinesmedicinal herbal preparations; antibiotics; antiseptics; chemico-pharmaceutical productschemical preparations for pharmaceutical or medical purposesfor the treatment of cancercentral nervous system disorderscardiovascularimmunologicalgastrointestinalmetabolic and infectious diseases; pharmaceutical productspharmaceutical products for the treatment of cancercentral nervous system disorderscardiovascularimmunologicalgastrointestinalmetabolic and infectious diseases * for human use * ; dietetic substances for medical usedietetic foods adapted for medical purposes; remedies for human medicinenatural remedy preparations for the treatment of gastrointestinal conditionshormonal and chemical imbalancessleep disorder
Class 10
Surgical and medical apparatus and instruments especially for the diagnosis and treatment of tumorssurgical apparatus and instruments for use in oncologic surgerylasers for surgical and medical usemedical imaging devicesultrasound imaging apparatusscanners and needle guidesparts and fittings therefor; surgical and medical apparatus and instruments especially for monitoring and modifying metabolic functionsheart rate monitoring apparatusmedical apparatus and instruments for monitoring vital signsblood properties and respiratory eventsdevices for monitoring blood glucose for medical purposes; surgical and medical apparatus and instruments especially for the diagnosis and treatment of brain diseases and disordersmedical imaging devices for the brainmedical devices for monitoring vital signsblood properties and respiratory eventsmedical devices for monitoring brain's electrical activitymedical devices for monitoring cognitive and motor functions during neurosurgerymedical apparatus and instrument for diagnostic useapparatus for medical diagnostic testing in the fields of neurodegenerative diseases; surgical apparatus and instruments for deep brain stimulationelectrical transcranial stimulationtranscranial direct-current stimulationtranscranial magnetic stimulationany form of electromagnetic stimulationlightmagnetic fieldelectric fieldradio frequency or ultrasound stimulationlow level laser therapynear-infrared light-emitting deviceselectric devices for deep brain stimulationwire coil devices for magnetic stimulationscalp electrodes for transcranial direct-current stimulationmedical radiofrequency apparatusmedical ultrasound apparatuselectrical stimulation apparatus for scalpnervesskinmuscles for physical therapy purposes; apparatus for the delivery of diagnostic or therapeutic agentsmedical apparatus and units for dosagemeasuring and monitoringdrug delivery devices and systems and organ oxygenation and perfusion apparatus; testing apparatus for medical usemedical imaging devices for monitoring oxygen level in the brainmedical imaging devices for monitoring glucose level in the brainmedical imaging devices for monitoring proteins level in the brainmicrodialysis devices for monitoring proteins level in the cerebrospinal fluidmedical devices for monitoring the brain's electrical activity; diagnostic apparatus for medical usemedical diagnostic apparatus for testing the brain's electrical activityoxygen level in the brainglucose level in the brainproteins level in the brain; Medical apparatus for the recording of electrical brain activityelectrodeselectroencephalographmicro-electrode arrays; apparatus for electrophysiologymedical electrodes for patch-clamp devicescurrent-clamp devicesvoltage-clamp devicesmicro-electrode arrays devices; apparatus for neuronal modelingmedical imaging apparatus incorporating medical imaging software and computational software sold as a unit therewith
Class 42
Scientific and technological services namelyscientific research and research and design in the field of nanomedicine in the nature of nanotechnology applied to medicine; biological research services; bacteriological research services; electrophysiological research; research in neuronal modeling; Testinganalysis and evaluation of service providers to determine conformity with established accreditation standardsevaluationsestimates and research in scientific and technological fields provided by engineers and researchers; design and development of new products for third parties; technical project studiestechnical research in the field of pharmaceutical project studies; industrial analysis and research services in the field of biomedical research; chemical analysis; chemical research; chemistry serviceschemistry consultation; surveyingconducting engineering surveys; research and development of new products for others; technical research in the field of pharmaceutical studies; research in the field of neuroscience; research in radio-biology; research in nanoscience and nanotechnologyespecially applied to medicine
Class 44
Healthcare especially in the field of nanomedicine; medical services especially in the field of nanomedicine; hospital services; medical assistance; physiotherapy
Publications
History of USPTO decisions and trademark events.
43 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/23/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/31/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/31/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/31/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/31/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/31/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/31/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/31/2023
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
07/11/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06/23/2020
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
03/09/2020
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
03/07/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/22/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/02/2019
FIMP
FINAL DISPOSITION PROCESSED
11/02/2019
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/01/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/23/2019
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
10/17/2019
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
10/16/2019
PLGL
ASSIGNED TO PARALEGAL
10/16/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2019
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
05/31/2019
PUBO
PUBLISHED FOR OPPOSITION
05/07/2019
GPNX
NOTIFICATION PROCESSED BY IB
05/03/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/17/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/17/2019
NPUB
NOTICE OF PUBLICATION
04/17/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2019
CNEA
EXAMINERS AMENDMENT MAILED
03/25/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
03/22/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/22/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/15/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/15/2019
RFNP
REFUSAL PROCESSED BY IB
01/25/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/05/2019
RFRR
REFUSAL PROCESSED BY MPU
01/05/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/20/2018
CNRT
NON-FINAL ACTION WRITTEN
12/19/2018
DOCK
ASSIGNED TO EXAMINER
12/19/2018
MAFR
APPLICATION FILING RECEIPT MAILED
12/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/30/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/29/2018
Continuous trademark protection
Get notified about every new filing that threatens OOCUITY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.